XML 49 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Summary of Outstanding Non-cancelable Purchase Obligations

As of December 31, 2023, the Company had the following outstanding non-cancelable purchase obligations (in thousands):

		Purchase Obligations Due In The Year Ending December 31,
		2024				2025				Total
Manufacture and supply of pamrevlumab		$	17,995			$	4,827			$	22,822
Manufacture and supply of roxadustat			573				1,146				1,719
Other purchases and programs			11,750				—				11,750
Total		$	30,318			$	5,973			$	36,291

X

- References

No definition available.

+ Details

Name:	us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of unconditional purchase obligation recognized as liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 440
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482648/440-10-50-6

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-SubTopic 10
-Topic 470
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481544/470-10-50-1

+ Details

Name:	us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration